nanoSPACE

NanoSpace is a South Korean biotechnology company specializing in the development and manufacturing of advanced lipid nanoparticle (LNP) delivery systems for mRNA therapeutics and vaccines. The company operates as both a platform developer and a contract development and manufacturing organization (CDMO), providing end-to-end solutions for nucleic acid delivery. Their core technology focuses on optimizing LNP formulations to improve the stability, safety, and tissue-specific targeting of genetic medicines. NanoSpace aims to address the critical bottleneck in the genomic medicine field by offering scalable, high-efficiency delivery vehicles for a wide range of indications, including oncology and infectious diseases. The company is positioned as a key player in the burgeoning mRNA ecosystem in East Asia.